LimmaTech Biologics is a biopharmaceutical company focused on the development and manufacture of pharmaceuticals. It offers CustomGlycan Platform, technology for producing monoclonal antibodies with functionality through glycosylation. The company is engaged in in vivo carbohydrate engineering.